DEVELOPMENT AND CLINICAL MASTER SERVICES AGREEMENTDevelopment and Clinical Master Services Agreement • March 9th, 2021 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New Jersey
This Development and Clinical Master Services Agreement (this “Agreement”) is effective as of December 17, 2020 (the “Effective Date”) by and between Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, a Delaware corporation (“Cambrex”), and Evelo Biosciences, Inc., a Delaware corporation (“Client”).
